Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage dependent anion channel 1 pseudogene 8 (VDAC1P8) is one of multiple human pseudogenes derived from the gene encoding voltage-dependent anion channel 1 (VDAC1), a mitochondrial ion channel involved in cellular metabolism and apoptosis. Unlike its parental gene, VDAC1P8 typically does not encode a functional protein. Recent research demonstrates that VDAC1P8 is transcribed in specific tissues, particularly showing high expression in acute myeloid leukemia where its overexpression is correlated with reduced VDAC1 levels, suggesting a regulatory role through a noncoding RNA mechanism. VDAC1P8 is thus a member of the growing class of pseudogenes with putative roles in gene regulation, especially in cancer biology[4][5].
None known for drugs; VDAC1P8 may act by modulating RNA networks as a ceRNA, but there is no direct mechanism of action relevant to therapies[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage dependent anion channel 1 pseudogene 8 (VDAC1P8).